To include your compound in the COVID-19 Resource Center, submit it here.

FAS/FASL pathway involved in immunotherapy resistance

A study published in Nature Communications by researchers at the Ludwig Institute for Cancer Research and colleagues identified Fas ligand (TNF superfamily, member 6; FASL) as

Read the full 262 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE